FBIOX Mutual Fund (Fidelity Select Biotechnology Portfolio) is managed by Fidelity Investments (US) with $7.10B in net assets. FBIOX expense ratio is 0.62%, holding 191 positions across sectors including Health Care, Unknown, Financials. Inception date: 1985-12-16.

FBIOX performance shows a YTD return of 21.38%. The 1-year return is 70.95% and the 5-year return is 9.23%. FBIOX dividend yield stands at 5.58%, paid semi-annually.

FBIOX top holdings include Abbvie Inc (13.2%), Krystal Biotech Inc (9.3%), Gilead Sciences Inc (8.8%), Amgen Inc. (8.3%), Alnylam Pharmace (3.1%). View all FBIOX holdings, sector breakdown, or dividend history.

FBIOX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBIOX alternatives are available via the screener, along with tax-loss harvesting opportunities.